Gill, Jason,Loadman, Paul,Falconer, Robert,Patterson, Laurence,Atkinson, Jennifer,Bibby, Michael
申请号：
LT12160565
公开号：
LT2481429T
申请日:
2008.03.27
申请国别(地区):
LT
年份:
2018
代理人:
摘要：
The present invention relates to compounds, and pharmaceutically acceptable salts thereof, comprising a vascular disrupting agent (VDA) associated and a MMP proteolytic cleavage site. The compounds are useful in the treatment of cancer.
